6533b85efe1ef96bd12bf8e2
RESEARCH PRODUCT
Post-surgical intestinal dysbiosis: use of an innovative mixture (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01).
Luigi BonavinaAndrea AriniLeonerdo FicanoDonato IannuzzielloLuigi PasqualeSalvo Emanuele AragonaGiorgio CiprandiRaffaele AnnicchiaricoBucci AntongiulioArrigo ArrigoniStefano BargiggiaPaolo Beretta Berni Canani MarcellaAntonino BertinoFilippo BovaGiampaolo BresciCarmelo BudaSalvatore CamilleriSte-fania CaronnaGregorio Cavallo Chahin Nabil JamilVirgilio ClaraSelvaggio CorradoGiovanni CozzoliUgo CrescenziRaimondo DarioFrancesco D’arpaAntonello DattolaDavide DeianaArmando Dell’anna Di Fenza Sergio Di Lorenzo Fernando Di Napoli An-geloVittorio D’onofrioGiovanni FerriniDomenico FerrulliRoberto FinizioNicola Gaffuri Garcea Maria RitaSalvatore GenovaPietro GiorgioMaurizio GiovannoneGiuliana GiuseppeGiovanni GuarnieriRenzo GullottaGiuseppe LeonardiGiovanni MagrìTammaro MaistoMariagrazia MancinoGianpiero ManesSantino MarchiRenato MarinMaria MarinoManuele MazziFrancesca Menasci Morabito Lo Prete AntonioFrancesca Murer Neri Bortoluzzi FrancescoSocrate PallioAntonio PalmaDa-vide PardocchiAntonio Pinto Pio Palieri AntonioAntonio PisaniAntonello PriviteraRaffaela PulitanòRossella PumpoFrancesco QuatraroIvana RaguzziCesarina RainisioGiulia RazzoliniOlimpia RevelloNicita RinaldoGiuseppe RivelliniGuidorenato SabadiniMarcello SalviaGennaro SarrantonioEdoardo SavarinoAntonella ScarcelliPietro SchettinoAngelo SchicchiLuigi SchiffinoLuca SediariEndrit ShainiCristiano SpadaFernando SpinelliLorenza TifiClaudio TrovatoRoberto VassalloMaurizio VintiFrancesca ZappatoreClaudio. Zullisubject
MaleLactobacillus delbrueckiiProbioticsDigestive surgery dysbiosis microbiota probiotic surveydysbiosisMiddle AgedGastrointestinal MicrobiomeLactobacillusPostoperative ComplicationsTreatment OutcomeAbdomenmicrobiotaHumansdigestive surgeryFemaleOriginal ArticlesurveyprobioticLactobacillus plantarumdescription
Abdominal surgery represents a high risk for hospital-acquired infections and complication that may compromise the surgery outcome. Patients with recent abdominal surgery have an intestinal dysbiosis. There is evidence that probiotics may counterbalance the impaired microbiota. Therefore, the current survey evaluated the efficacy and safety of Abincol®,an oral nutraceuticalcontaining a probiotic mixture with Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 millions of living cells), and Lactobacillus delbrueckii LDD01 (200 millions of living cells), in 612 outpatients (344 males and 268 females, mean age 58 years) undergoing digestive surgery. Patients took 1 stick/daily for 8 weeks. Abincol® significantly diminished the presence and the severity of intestinal symptoms and improved stool form. In conclusion, the current survey suggests that Abincol® may be considered an effective and safe therapeutic option in the management of patients undergoing digestivesurgery. (www.actabiomedica.it)
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2019-07-02 | Acta bio-medica : Atenei Parmensis |